Submitted by dcc on Fri, 2018-03-16 17:37 Study Title: A phase I study of single agent tazemetostat in subjects with advanced solid tumors and B-cell lymphomas with hepatic dysfunctionCIRB: Adult CIRB - Early Phase EmphasisLead Group: ETCTNStatus: CompletedReview Status: Completed
